EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 -0.0512
March 31, 2026 -1.324
December 31, 2025 -0.0901
September 30, 2025 -0.143
June 30, 2025 -0.0707
March 31, 2025 -0.9508
December 31, 2024 -0.5136
September 30, 2024 -1.125
June 30, 2024 -1.814
March 31, 2024 -0.081
December 31, 2023 -0.0879
September 30, 2023 -1.498
June 30, 2023 -0.0766
March 31, 2023 -0.1114
December 31, 2022 0.0677
Date Value
September 30, 2022 -0.0294
June 30, 2022 -0.0553
March 31, 2022 -0.0883
December 31, 2021 -0.10
September 30, 2021 -0.1789
June 30, 2021 -0.1009
March 31, 2021 -0.0703
December 31, 2020 -0.1635
September 30, 2020 -0.0668
June 30, 2020 -0.0771
March 31, 2020 -0.0928
December 31, 2019 -0.1239
September 30, 2019 -0.2108
June 30, 2019 0.0534
March 31, 2019 0.0372

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
LataMed AI Corp. -0.0004
SCWorx Corp. -1.355
Health Catalyst, Inc. -0.5481
GoodRx Holdings, Inc. 0.0245
Claritev Corp. -3.491